Regression of advanced maxillary sinus cancer with orbital invasion by combined chemotherapy and immunotherapy: A one-year follow-up case report

化疗联合免疫疗法使伴有眼眶侵犯的晚期上颌窦癌消退:一例一年随访病例报告

阅读:1

Abstract

A case of advanced maxillary cancer undergoing a combination of chemotherapy and immunotherapy is reported. The subject a 59-year-old man had a history of nasopharyngeal carcinoma treated with concurrent chemoradiotherapy in 2004. The patient was diagnosed with a right maxillary sinus carcinoma invading the right orbital fossa (cT4aN0M0, stage IVA) in 2019. Computed tomography revealed soft tissue swelling involving the right maxillary sinus, right nasal cavity, inferior extraconal space of the right eye, right cheek and right hard palate with extension into the right pterygopalatine fossa. The patient refused surgery and radiotherapy but accepted chemotherapy in combination with immunotherapy. A marked regression of advanced maxillary sinus cancer with orbital invasion using this regimen was noted in the one-year follow-up period. A literature review on treatment for advanced maxillary sinus cancer was also conducted and the results revealed that this combination regimen may play a role in the treatment of advanced maxillary sinus cancer but further investigation is required to determine the effect of combination of chemotherapy and immunotherapy on advanced maxillary sinus cancer.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。